000 00925 a2200265 4500
005 20250517183134.0
264 0 _c20190701
008 201907s 0 0 eng d
022 _a1526-632X
024 7 _a10.1212/WNL.0000000000004699
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMcDonnell, Gavin V
245 0 0 _aComorbidities in MS are associated with treatment intolerance and disability.
_h[electronic resource]
260 _bNeurology
_c11 2017
300 _a2218-2219 p.
_bdigital
500 _aPublication Type: Editorial
650 0 4 _aComorbidity
650 0 4 _aHumans
650 0 4 _aImmunologic Factors
_xadverse effects
650 0 4 _aMultiple Sclerosis
_xepidemiology
650 0 4 _aSeverity of Illness Index
700 1 _aCohen, Jeffrey A
773 0 _tNeurology
_gvol. 89
_gno. 22
_gp. 2218-2219
856 4 0 _uhttps://doi.org/10.1212/WNL.0000000000004699
_zAvailable from publisher's website
999 _c27744297
_d27744297